Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis

Journal of Neurochemistry

Volumn 74, Issue 4, 2000, Pages 1621-1626

  Choi, Won Seok ^a   Yoon, So Young ^a   Chang, In Ick ^a   Choi, Eui Ju ^b   Rhim, Hyewhon ^c   Jin, Byung K ^d   Oh, Tae H ^e   Krajewski, Stanislaw ^f   Reed, John C ^f   Oh, Young J ^a  

^a Yonsei University   (South Korea)

^b Korea University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Ajou University School of Medicine   (South Korea)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f BURNHAM INSTITUTE   (United States)

Author keywords

Apoptosis; Bcl 2 homology domain; MN9D; Parkinson's disease

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE; CASPASE INHIBITOR; MUTANT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; ENZYME INHIBITION; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

APOPTOSIS; CASPASES; CELLS, CULTURED; DOPAMINE; ENZYME INHIBITORS; HUMANS; IN SITU NICK-END LABELING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NEURONS; PARKINSON DISEASE; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; STAUROSPORINE; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 17144441040     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0741621.x     Document Type: Article

References (39)

1. Adams J. M. and Cory S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1325.
2. Alnemri E. S., Robertson N. M., Fernandes T. F., Croce C. M., and Litwack G. (1992) Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. Proc. Natl. Acad. Sci. USA 89, 7295-7299.
3. Alnemri E. S., Livingston D. J., Nicholson D. W., Salvesen G., Thornberry N. A., Wong W. W., and Yuan J. (1996) Human ICE/CED-3 protease nomenclature. Cell 87, 171.
4. Borner C., Martinou I., Mattmann C., Irmler M., Schaerer E., Martinou J. C., and Tschopp J. (1994) The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol. 126, 1059-1068.
5. L. Nature 379, 554-556.
6. +-induced dopaminergic neuronal cell death: Role of caspases, ROS and JNK. J. Neurosci. Res. 57, 86-94.
7. Cryns V. and Yuan J. (1998) Proteases to die for. Genes Dev. 12, 1551-1570.
8. Gavrieli Y., Sherman Y., and Ben-Sasson S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
9. Ham J., Babij C., Whitfield J., Pfarr C. M., Lallemand D., Yaniv M., and Rubin L. L. (1995) A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927-939.
10. Hansen M. B., Nielson S. E., and Berg K. (1989) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210.
11. Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., and Korsmeyer S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
12. Huang D. C. S., Adams J. M., and Cory S. (1998) The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 17, 1029-1039.
13. Kane D. J., Ord T., Anton R., and Bredesen D. E. (1995) Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40, 269-275.
14. Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., and Poirier G. G. (1993) Specific proteolytic cleavage of poly(ADP-ribose)polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976-3985.
15. L. Mol. Cell. Biol. 17, 7040-7046.
16. L and caspase inhibitors during staurosporine-induced dopaminergic neuronal apoptosis. J. Neurochem. 72, 2456-2463.
17. Kluck R. M., Bossy-Wetzel E., Green D. R., and Newmeyer D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136.
18. Krajewski S., Tanaka S., Takayama S., Schibler M. J., Fenton W., and Reed J. C. (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53, 4701-4714.
19. Kroemer G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3, 614-620.
20. Lazebnik Y. A., Kaufmann S. H., Desnoyers S., Poirier G. G., and Earnshaw W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
21. 2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J. Biol. Chem. 273, 33091-33098.
22. Nguyen M., Millar D. G., Yong V. W., Korsmeyer S. J., and Shore G. C. (1993) Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem. 268, 25265-25268.
23. Nguyen M., Branton P. E., Walton P. A., Oltvai Z. N., Korsmeyer S. J., and Shore G. C. (1994) Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem. 269, 16521-16524.
24. Oh J. H., Choi W. S., Kim J. E., Seo J. W., O'Malley K. L., and Oh Y. J. (1998) Overexpression of HA-Bax but not Bcl-2 and Bcl-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis. Exp. Neurol. 154, 193-198.
25. Oh Y. J., Uhland-Smith A., Kim J.-E., and O'Malley K. L. (1997) Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death. Mol. Brain Res. 51, 133-142.
26. Oltvai Z. N., Milliman C. L., and Korsmeyer S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
27. Park J., Kim I., Oh Y. J., Lee K. W., Han P. L., and Choi E. J. (1997) Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2. J. Biol. Chem. 272, 16725-16728.
28. Reed J. C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6.
29. Tanaka S., Saito K., and Reed J. C. (1993) Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival. J. Biol. Chem. 268, 10920-10926.
30. Thompson C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
31. Verheij M., Bose R., Lin X. H., Yao B., Jarvis W. D., Grant S., Birrer M. J., Szabo E., Zon L. I., Kyriakis J. M., Haimovitz-Friedman A., Fuks Z., and Kolesnick R. N. (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380, 75-79.
32. Virdee K., Bannister A. J., Hunt S. P., and Tolkovsky A. M. (1997) Comparison between the timing of JNK activation, c-Jun phosphorylation, and onset of death commitment in sympathetic neurons. J. Neurochem. 69, 550-561.
33. Wang H. G., Takayama S., Rapp U. R., and Reed J. C. (1996) Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA 93, 7063-7068.
34. Wang K., Yin X. M., Chao D. T., Milliman C. L., and Korsmeyer S. J. (1996) BID: a novel BH3 domain-only death agonist. Genes Dev. 10, 2859-2869.
35. Wyllie A. H. (1993) Apoptosis. Br. J. Cancer 67, 205-208.
36. Xia Z., Dickens M., Raingeaud J., Davis R. J., and Greenberg M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
37. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., and Wang X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
38. Yin X. M., Oltvai Z. N., and Korsmeyer S. J. (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 321-323.
39. Zanke B. W., Lee C., Arab S., and Tannock I. F. (1998) Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1 beta-converting enzyme inhibition. Cancer Res. 58, 2801-2808.